• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE XPEDITION; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE XPEDITION; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1074400-18
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes Cardiac Arrest (1762); Low Blood Pressure/ Hypotension (1914); Occlusion (1984)
Date of Event 01/23/2020
Type of Reportable Event Death
Additional Manufacturer Narrative
(b)(4).The stent remains in patient.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.The 2.5x30 trek and 2.5x38 xience xpedition referenced are being filed under separate medwatch report numbers.
 
Event or Problem Description
It was reported that the 2.5x30 mm trek dilatation catheter was inflated three times in the calcified mid left anterior descending (lad) coronary artery.It was inflated at 14 atmospheres (atms), 20 atms and 18 atms when the trek ruptured.During removal of the trek, the balloon separated and remained in the artery.Attempts made to remove/snare out the separated segment of the trek were not successful.A vessel perforation occurred in the mid lad during use of a non-abbott dilatation catheter, but the patient remained stable.The 2.5x38 mm xience xpedition stent was deployed at 12 atms for 15 sec, then 12 atm for 22 sec, then 20 atm for 15 sec, and 5 atm for 11 sec in the mid lad over the separated trek balloon; however, the stent delivery system (sds) did not fully deflate and was difficult to remove from the guide catheter, so the sds and guide catheter were removed together as a unit.The patient remained stable.A 3.5x38 mm xience xpedition stent was implanted in the proximal lad and a 4.0x12 mm xience xpedition stent was implanted in the ostial left main coronary artery.A 4.0 x 18 mm xience xpedition stent was implanted in the predilated left main to left circumflex.After post dilatation of the 4.0x18 mm xience xpedition stent using a non-abbott dilatation catheter, the blood pressure dropped and cardiac arrest occurred.There was no reflow in the lad.The patient was ventilated and three doses of epinephrine were administered, but the blood pressure was gone.No further attempts to resuscitate the patient were performed because the patient was a do not resuscitate.The patient expired.No additional information was provided.
 
Additional Manufacturer Narrative
The device was not returned for evaluation.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effects of hypotension, occlusion and death are listed in the xience xpedition everolimus eluting coronary stent systems instructions for use as known patient effects of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined; however, it should be noted that a medical review was performed by an abbott vascular clinical specialist who concluded the xience xpedition des 4.00x18 rx was not directly related to the patient¿s death.There is no indication of a product quality issue with respect to manufacture, design or labeling.Na.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE XPEDITION
Common Device Name
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
MDR Report Key9707781
Report Number2024168-2020-01473
Device Sequence Number14321407
Product Code NIQ
UDI-Device Identifier08717648162640
UDI-Public08717648162640
Combination Product (Y/N)Y
Initial Reporter CountryCA
PMA/510(K) Number
P110019
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2020
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 04/29/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date09/08/2022
Device Model Number1074400-18
Device Catalogue Number1074400-18
Device Lot Number9090441
Was Device Available for Evaluation? No
Initial Date Received by Manufacturer 01/29/2020
Supplement Date Received by Manufacturer04/17/2020
Initial Report FDA Received Date02/13/2020
Supplement Report FDA Received Date04/29/2020
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
DILATATION CATHETERS: 4.0X15 SPRINTER; XIENCE XPEDITION (2.5X38, 3.5X38, 4.0X12); DILATATION CATHETERS: 4.0X15 SPRINTER; XIENCE XPEDITION (2.5X38, 3.5X38, 4.0X12)
Outcome Attributed to Adverse Event Death;
Patient Age82 YR
Patient Weight48
-
-